News + Font Resize -

PAREXEL opens new European coordination hub and distribution center in Germany
Boston, Massachusetts | Wednesday, November 12, 2014, 09:00 Hrs  [IST]

PAREXEL International Corporation (PRXL), a leading global biopharmaceutical services provider, has opened its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany.  

The facility expands the company's capacity to provide comprehensive clinical trial supply and logistics services to support clients’ local, regional and global trial requirements.  These capabilities include synchronized coordination of clinical trial supplies, ancillary supplies and central laboratory services.

“To safely and efficiently conduct clinical trials, our customers need highly specialized clinical supply and logistics services for studies that can span dozens of countries and hundreds of sites around the world,” said Mark A. Goldberg, president and chief operating officer, PAREXEL. “Our new European distribution center reflects a commitment to simplify the important end-to-end supply-management aspect of the drug-development journey.”

The facility features more than 65,000 cubic meters of storage space.  It offers lab-kit assembly and provides storage and distribution of ancillary materials.

“Through this center, we can customize sourcing and distribution strategies for customers in ways that are efficient, robust and compliant with local regulations,” said Thomas Senderovitz, senior vice president, clinical research services, PAREXEL.  “In addition, from this central location, we can provide responsive, timely delivery services to all EU destinations.”

The new European Coordination Hub and Distribution Center will be licensed to store Investigational Medicinal Products (IMPs) and Non-Investigational Medicinal Products (N-IMPs).  It will also offer secondary packaging, re-labeling, and compliance with Good Distribution Practice (GDP) of medical devices and ambient, refrigerated and frozen medicinal products, including controlled substances.  On-site Qualified Person (QP), Quality Control (QC) and production personnel will manage regulatory-compliance requirements.  They will also streamline product import, receipt, storage, packaging and labeling, release, shipment, return and destruction timelines.

PAREXEL also is opening new full-service clinical trial supply depots in Buenos Aires, Argentina, and São Paulo, Brazil.  The facilities are part of PAREXEL’s growing global system of more than 50 owned or in-network depots and three regional distribution centers.  They are designed to help ensure a seamless flow of materials and timely clinical site supply delivery around the world.

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Post Your Comment

 

Enquiry Form